Intracellular IL-17 signaling during Coxiella burnetii infection
Intracellular IL-17 signaling during Coxiella burnetii infection
批准号:
10295139
负责人:
STACEY D GILK
金额:
$18.45万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-07-01 至 2022-06-30
中文摘要
项目总结/文摘
英文摘要
PROJECT SUMMARY/ABSTRACT
Coxiella burnetii is an obligate intracellular bacterium and the etiological agent of Q fever. During natural infection
Coxiella targets alveolar macrophages, where the bacterium promotes formation of a phagolysosome-like
vacuole called the Coxiella Containing Vacuole (CCV). Successful host cell infection requires the Type IVB
Secretion System (T4BSS), which translocates bacterial effector proteins across the CCV membrane into the
host cytoplasm, where they manipulate a variety of cell processes. We recently demonstrated that the Coxiella
T4BSS downregulates expression of IL-17 target genes as well as IL-17-stimulated chemokine secretion.
Further, the Coxiella T4BSS confers protection against IL-17 mediated killing by the macrophage. IL-17 is a pro-
inflammatory cytokine that has a key role in the innate immune response against pulmonary pathogens. Upon
IL-17 binding, the macrophage surface IL-17 receptor activates several intracellular signaling pathways through
the E3-ubiquitin ligase ACT1. Unphosphorylated ACT1 ubiquitinates TRAF6, triggering transcriptional activation
of IL-17 target genes, while phosphorylated ACT1 recruits TRAF2/5, binds to the 3’ mRNA of IL-17 target genes
and stabilizes the mRNA for translation. The proposed experiments will test our hypothesis that Coxiella!T4BSS
effector proteins downregulate intracellular IL-17 signaling pathway(s) in order to evade the host innate immune
response and promote bacterial pathogenesis. Aim 1 will determine whether Coxiella targets the ACT1-TRAF6
pathway to downregulate IL-17 target gene transcription. Aim 2 will test whether Coxiella destabilizes the mRNA
of IL-17 target genes through ACT1-TRAF2/5. Completion of these studies will not only reveal a specific host
innate immune response used against C. burnetii, but also a novel strategy employed by pathogens to escape
the immune response during the initial stages of infection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Coxiella survival mechanisms in the intracellular niche
-
批准号:10664843
-
项目类别:
-
资助金额:$55.16万
-
财政年份:2022
-
负责人:STACEY D GILK
-
依托单位:
Coxiella survival mechanisms in the intracellular niche
-
批准号:10797442
-
项目类别:
-
资助金额:$5.47万
-
财政年份:2022
-
负责人:STACEY D GILK
-
依托单位:
Coxiella secreted proteins mediating inter-organelle membrane contact sites
-
批准号:10575434
-
项目类别:
-
资助金额:$23.03万
-
财政年份:2022
-
负责人:STACEY D GILK
-
依托单位:
Coxiella survival mechanisms in the intracellular niche
-
批准号:10375875
-
项目类别:
-
资助金额:$58.34万
-
财政年份:2022
-
负责人:STACEY D GILK
-
依托单位:
Intracellular IL-17 signaling during Coxiella burnetii infection
-
批准号:10201507
-
项目类别:
-
资助金额:$19.13万
-
财政年份:2020
-
负责人:STACEY D GILK
-
依托单位:
Intracellular IL-17 signaling during Coxiella burnetii infection
-
批准号:10063664
-
项目类别:
-
资助金额:$1.36万
-
财政年份:2020
-
负责人:STACEY D GILK
-
依托单位:
Coxiella manipulation of cholesterol in the intracellular niche
-
批准号:10270536
-
项目类别:
-
资助金额:$35.9万
-
财政年份:2020
-
负责人:STACEY D GILK
-
依托单位:
Coxiella manipulation of cholesterol in the intracellular niche
-
批准号:9919527
-
项目类别:
-
资助金额:$5.95万
-
财政年份:2018
-
负责人:STACEY D GILK
-
依托单位:
Coxiella manipulation of cholesterol in the intracellular niche
-
批准号:10386854
-
项目类别:
-
资助金额:$42.29万
-
财政年份:2018
-
负责人:STACEY D GILK
-
依托单位:
Reprogramming of host cell cholesterol homeostasis by Coxiella burnetii
-
批准号:9195715
-
项目类别:
-
资助金额:$19.25万
-
财政年份:2015
-
负责人:STACEY D GILK
-
依托单位:
Reprogramming of host cell cholesterol homeostasis by Coxiella burnetii
-
批准号:9016852
-
项目类别:
-
资助金额:$23.08万
-
财政年份:2015
-
负责人:STACEY D GILK
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于“大气下陷”理论探讨升陷汤调控IL-17A/IL-17RA信号轴抑制MMP-2/MMP-9表达抗心衰大鼠心肌纤维化的作用机制
-
批准号:2026JJ80502
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王雪
-
依托单位:
儿童腺样体肥大中肠道菌群-免疫轴通过GPR43对IL-17A的调控作用
-
批准号:2026JJ80288
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:郭睿
-
依托单位:
KIF4A通过激活IL-17/NF-κB信号通路促进三阴性乳腺癌恶性进展的机制研究
-
批准号:JCZRQNB202601048
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
感觉神经元上 IL17ra 调控银屑病慢性瘙痒机制研究
-
批准号:JCZRQNB202600192
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
脆弱拟杆菌通过Th17/IL-17A轴介导柔嫩艾美耳球虫引起的肉鸡肠道损伤
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:郭阳浩
-
依托单位:
基于PI3K/AKT/Th17/IL-17调控炎症微环境探讨肺复方改善肺癌免疫治疗应答的临床及机制研究
-
批准号:2026JJ82369
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:周坚
-
依托单位:
SPP1⁺巨噬细胞通过IL-8-EMT样转化-IL-17环路与滑膜成纤维细胞互作驱动类风湿关节炎难治性表型的机制研究
-
批准号:2026JJ50588
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李芬
-
依托单位:
温阳化气汤通过IL-17A/NF-kB通路调节恶性黑色素瘤中CXCL10介导的抗肿瘤免疫浸润的机制研究
-
批准号:JCZRLH202601136
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
S100B调控IL17A炎症信号参与腹主动脉瘤形成
-
批准号:JCZRLH202600165
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于“截断扭转”学说探讨凉膈散通过IL-6/STAT3/RORγt轴调控脓毒症Th17/Treg稳态的机制及临床研究
-
批准号:2026JJ82600
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:黄磊
-
依托单位: